Is FTO useful for weight loss?

The utility of the FTO gene (fat mass and obesity-associated) for weight loss is nuanced. Large GWAS have consistently linked the FTO risk allele (e.g., rs9939609) with higher BMI and obesity risk. Evidence is human-moderate: carriers of the risk allele tend to weigh about 3 kg more on average, show increased appetite, and prefer energy-dense foods. However, the effect size is modest and strongly modified by lifestyle. Intervention studies indicate that risk-allele carriers respond equally well—or even better—to structured weight-loss programs, especially those with higher protein or lower fat content. Thus, knowing one's FTO status does not currently enable personalized diet prescriptions that outperform standard approaches. The main practical value may be motivational: understanding a genetic predisposition could encourage adherence to healthy habits. Caveats: FTO testing is not diagnostic; it should not replace evidence-based weight management strategies. The overall impact of a single gene is small compared to diet, exercise, and behavior. Consumers should be wary of overhyped direct-to-consumer claims. In summary, FTO is of limited direct utility for weight loss; lifestyle interventions remain the cornerstone.